Data recently published in JAMA Oncology suggests individualized stereotactic ablative radiotherapy used to treat lung tumors may allow minimization of treatment dose, resulting in excellent tumor control among patients with...
In the realm of small cell lung cancer (SCLC), treatment standards have seen little evolution, with limited options and poor outcomes, especially in extended disease (ED) cases. The advent of immune checkpoint inhibitors (ICIs)...
Healthcare providers need patient data to provide the best care; however, patients are increasingly weary of providing this data. Here’s how to build trust.